Table 6 Summary of experimental data of fat cell glucose uptake
From: Pharmacodynamics and pharmacokinetics of a new type of recombinant insulin Lisargine injection
Samples | N = 1 | N = 2 | N = 3 | Mean ± SEM | P value | |
|---|---|---|---|---|---|---|
EC50 (nM) | EC50 (nM) | EC50 (nM) | vs S-Insulin | Lantus vs. Lisargine | ||
S-Insulin | 2.5 | 5.3 | 3.0 | 3.7 ± 0.5 | / | / |
Lantus | 1.6 | 3.8 | 2.9 | 3.0 ± 0.3 | 0.506 | / |
H-Insulin | 0.9 | 1.7 | 2.2 | 1.8 ± 0.2 | 0.102 | / |
Lisargine | 3.5 | 8.5 | 4.5 | 5.7 ± 0.9 | 0.333 | 0.178 |